How Specialty Distributors Support Patients with Rare Diseases

Post Date: November 22, 2022

The United States Food and Drug Administration (FDA) estimates that more than 30 million people living in the U.S. are affected by over 7,000 rare diseases. Many of these rare diseases do not have a known...

Tom Hart, Chief Operating Officer of BioCare, on “How Extreme Weather Affects Cold Supply Chains”

Post Date: November 11, 2022

Cold supply chains are necessary to ensure the efficacy of certain medications, vaccines and other biopharmaceutical products, but the addition of extreme temperatures presents new obstacles that can make the process even more difficult to manage...

Building Your Quality Management System From the Ground Up

Post Date: November 9, 2022

Your success as a pharmaceutical company heavily relies on the implementation of a quality management system. With ever-changing FDA regulations and technological advancements, the demand for solid infrastructure with quality in mind is increasing. Truthfully, the...

Is Your Organization Prepared for the Upcoming FDA Licensing Changes?

Post Date: November 2, 2022

The U.S. Food and Drug Administration (FDA) recently announced the proposed rule, which aims to create a uniform national licensing standard for wholesale distributors and third-party logistics providers (3PLs). Historically, states have set their own standards for...

How Distributors Can Help Address Challenges in Access to Specialty Drugs

Post Date: October 25, 2022

There are a variety of challenges that patients may face when accessing medication. In fact, a 2019 study on medication access identified 17 distinct barriers that patients must overcome, including costs, transportation, and geographical characteristics that can create...

Three Technologies Impacting Pharmaceutical Third-Party Logistics

Post Date: October 19, 2022

With all the challenges facing the global supply chain in recent years, including materials and labor shortages, it comes as no surprise that third-party logistics (3PL) providers are looking to utilize cutting edge technologies to create...

Tom Hart, Chief Operating Officer of BioCare, on “The Intricacies of the Pharma Cold Chain”

Post Date: October 14, 2022

Tom Hart, COO of BioCare, a specialty distributor of medications, discusses the ways to combat the cold chain-warmer temperatures dilemma, along with his future outlook on the industry supply chain as a whole.

Tips for Navigating Ever-Changing Quality & Regulatory Requirements in Healthcare

Post Date: October 11, 2022

The healthcare industry is one of the most highly regulated out there — and for good reason. When it comes to developing and then getting life-saving medications to patients, there is little room for error. Regardless...

BioCareSD Adds Six New Products to Existing Portfolio in Partnership with UCB

Post Date: October 5, 2022

BioCareSD, a specialty distributor of life-saving therapies, today announced a contract with UCB to add six new product offerings to its already diverse portfolio. This partnership, which will enable BioCareSD to service a wider patient population, demonstrates the organization’s continued...

Is a Limited Distribution Network Right for You?

Post Date: October 4, 2022

Over the past 5 years, the FDA has approved an average of 51 novel drugs annually. As a manufacturer prepares to bring any new drug to market, there are several important decisions to be made along...